The EKF MSG is dedicated to understanding the dynamic interplay between metabolic alterations and chronic inflammation. Central research themes include identifying the molecular basis of metaflammation, understanding its impact on disease progression, and exploring its role in modulating therapeutic responses, particularly in cancer immunotherapy. Combining expertise from metabolomics, immunology, oncology, and other fields, the program addresses these challenges through a multidisciplinary approach. The ultimate goal is to develop tailored diagnostic and therapeutic strategies that consider patients’ unique genetic, environmental, and lifestyle factors.
Universität zu Lübeck
Ratzeburger Allee 160
23562 Lübeck
Tel. +49 451 3101 0
Fax +49 451 3101 1004
Universitätsklinikum
Schleswig-Holstein (UKSH)
Tel. +49 451 500 0
für die Ukraine